摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,4,7,10-四硫环十二烷 | 25423-56-7

中文名称
1,4,7,10-四硫环十二烷
中文别名
四硫环十二烷
英文名称
1,4,7,10-tetrathiacyclododecane
英文别名
1,4,7,10-Tetrathiacyclododecan
1,4,7,10-四硫环十二烷化学式
CAS
25423-56-7
化学式
C8H16S4
mdl
MFCD00010829
分子量
240.479
InChiKey
MULBAFLKPUVJKC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    226-228 °C(lit.)
  • 沸点:
    160-162 °C0.5 mm Hg(lit.)
  • 密度:
    1.140±0.06 g/cm3(Predicted)
  • 稳定性/保质期:

    遵照规定使用和储存,则不会发生分解。

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    101
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S37/39
  • 危险类别码:
    R36/37/38
  • WGK Germany:
    3
  • 危险标志:
    GHS07
  • 危险性描述:
    H315,H319,H335
  • 危险性防范说明:
    P261,P305 + P351 + P338
  • 储存条件:
    存放于阴凉干燥处

SDS

SDS:6c1bbd3f09579646d8f93dd18efb226d
查看

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 1,4,7,10-Tetrathiacyclododecane
CAS-No. : 25423-56-7
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Skin irritation (Category 2)
Eye irritation (Category 2)
Specific target organ toxicity - single exposure (Category 3)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Irritating to eyes, respiratory system and skin.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Warning
Hazard statement(s)
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
Precautionary statement(s)
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
Safety data sheet available on request.
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R36/37/38 Irritating to eyes, respiratory system and skin.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
S37/39 Wear suitable gloves and eye/face protection.
Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Synonyms : 12-Ane-S4
Formula : C8H16S4
Molecular Weight : 240,47 g/mol
Component Concentration
1,4,7,10-Tetrathiacyclododecane
CAS-No. 25423-56-7 -

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Sulphur oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: powder
Colour: white
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 226 - 228 °C - lit.
point
f) Initial boiling point and 160 - 162 °C at 0,7 hPa - lit.
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. Causes respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. Causes skin irritation.
Eyes Causes serious eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine Pollutant: no IATA: no
Special precautions for user
no data available

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

Section 16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    硫醚大环配合物家族中异常的结构变异。[12]-,[14]-和[16] -ANES 4的卤化锡(IV)加合物
    摘要:
    水解敏感化合物[(SnCl 4)2([ n ] aneS 4)](n = 12、14、16)和[SnBr 4([ n ] aneS 4)]以2 mol的反应高收率获得。当量 母体四卤化锡与1 mol。当量 的大循环在无水CH 2 Cl 2溶液中溶解。[16] aneSe 4与SnX 4 (X = Cl或Br)的反应得到[SnX 4([16] aneSe 4)],而[8] aneSe 2的反应得到[SnCl 4([8] aneSe 2)] 。三种密切相关的配合物[SnBr 4([12] aneS 4)],[SnBr 4([14] aneS 4)]·2 / 3CH 2 Cl 2和[SnBr 4([16] aneS 4)的晶体结构。]已经确定。这些物种代表了Sn(IV)中性16族卤化物加合物配体采用聚合物结构。复杂的都是连锁店聚合物,尽管对 大循环环大小,给每个独特的结构形式。通常,[SnBr 4([14]
    DOI:
    10.1039/b307863a
  • 作为产物:
    描述:
    3,6-二硫杂-1,8-辛二醇盐酸caesium carbonate硫脲 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 3.0h, 生成 1,4,7,10-四硫环十二烷
    参考文献:
    名称:
    Yatsimirskii, K. B.; Pavlishchuk, V. V.; Strizhak, P. E., Journal of general chemistry of the USSR, 1987, vol. 57, p. 2453 - 2457
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Synthesis, characterisation and structures of thio-, seleno- and telluro-ether complexes of indium(III) halides
    作者:Chitra Gurnani、Marek Jura、William Levason、Raju Ratnani、Gillian Reid、Michael Webster
    DOI:10.1039/b816148h
    日期:——
    [(InCl(3))(2)micro(2)-o-C(6)H(4)(CH(2)SMe)(2)}] and [(InCl(3))(2)micro(2)-MeTe(CH(2))(3)TeMe}] are formed even from a 1:1 In:ligand ratio. Key structure types were confirmed from crystal structures of [InCl(2)RSe(CH(2))(2)SeR}(micro-Cl)(2)InCl(2)RSe(CH(2))(2)SeR(2)}] (R = Me or (n)Bu), trans-[InX(2)(i)PrS(CH(2))(2)S(i)Pr}(2)][InX(4)] (X = Cl or Br), trans-[InBr(2)MeSe(CH(2))(2)SeMe}(2)][InBr(4)]
    (III)卤桥八面体二聚体[InX(2)(LL)(mu-X)(2)InX(2)(LL)](X = Cl:LL = MeS(CH(2))(2 )SMe,MeSe(CH(2))(2)SeMe,(n)BuSe(CH(2))(2)Se(n)Bu),离子反式-[InX(2)(LL)(2) ] [InX(4)](X = Cl:LL =(i)PrS(CH(2))(2)S(i)Pr; X = Br:LL = MeS(CH(2))(2)SMe ,(i)PrS(CH(2))(2)S(i)Pr,MeSe(CH(2))(2)SeMe),顺式[InCl(2)(thiamacrocycle)] [InCl(4)] (杂大环= [12] aneS(4)或[14] aneS(4))和中性八面体[InCl(3)([9] aneS(3))]和[InCl(3)MeC(CH( 2)SMe)(3)}]是通过在无CH(2)C
  • Synthesis and structural studies on polymeric assemblies derived from antimony(III) halide complexes with bi- and tri-dentate and macrocyclic thio- and seleno-ether ligands
    作者:Andrew J. Barton、Nicholas J. Hill、William Levason、Gillian Reid
    DOI:10.1039/b100782n
    日期:——
    SbX3 (X = Cl, Br or in some cases I) reacts with one molar equivalent of L [L = MeS(CH2)2SMe, MeS(CH2)3SMe, MeSe(CH2)2SeMe, MeC(CH2SMe)3, MeC(CH2SeMe)3, [12]aneS4 (1,4,7,10-tetrathiacyclododecane), [14]aneS4 (1,4,8,11-tetrathiacyclotetradecane), [16]aneS4 (1,5,9,13-tetrathiacyclohexadecane), [8]aneSe2 (1,5-diselenacyclooctane) or [16]aneSe4 (1,5,9,13-tetraselenacyclohexadecane)] in anhydrous CH2Cl2, MeCN or thf solution to afford colourless to red-orange powdered solids involving a 1 ∶ 1 Sb ∶ L ratio in most cases, and occasionally a 2 ∶ 1 Sb ∶ L ratio. The crystal structures of [SbCl3MeS(CH2)2SMe}], [(SbBr3)2([14]aneS4)], [SbCl3MeC(CH2SMe)3}], [SbI3MeC(CH2SMe)3}] and [SbBr3MeC(CH2SeMe)3}] all exhibit infinite one- or three-dimensional networks which are assembled from distorted five or six coordinate Sb(III) with primary Sb–X bonding, secondary Sb–S or Sb–Se interactions and retention of the pyramidal SbX3 unit found in the parent halides. The structures of these compounds are discussed in terms of the bonding model used by others for antimony phosphine complexes. They are also compared with the structures of other reported thioether complexes of Sb(III), and with their Bi(III) analogues.
    SbX3(X = Cl,Br,或在某些情况下I)与一摩尔当量的L [L = MeS(CH2)2SMe,MeS( )3SMe,MeSe( )2SeMe,MeC( SMe)3,MeC( SeMe)3,[12]aneS4(1,4,7,10-四环十二烷),[14]aneS4(1,4,8,11-四硫杂环十四烷),[16]aneS4(1,5,9,13-四硫杂环十六烷),[8]aneSe2(1,5-二杂环八烷)或[16]aneSe4(1,5,9,13-四环十六烷)]在无 Cl2、MeCN或THF溶液中反应,生成大多数情况下Sb与L比例为1:1的无色至橙红色粉末固体,偶尔也有2:1的Sb与L比例。[SbCl3MeS( )2SMe}]、[(SbBr3)2([14]aneS4)]、[SbCl3MeC( SMe)3}]、[SbI3MeC( SMe)3}]和[SbBr3MeC( SeMe)3}]的晶体结构均显示由扭曲的五或六配位Sb(III)组成的无限一维或三维网络,这些网络由主要的Sb-X键合、次要的Sb-S或Sb-Se相互作用以及保留在母卤化物中的锥形SbX3单元组成。这些化合物的结构是根据其他人用于膦配合物的键合模型进行讨论的。它们还与报道的其他Sb(III)醚配合物及其Bi(III)类似物的结构进行了比较。
  • The catalytic synthesis of thiacrowns from thiiranes by Group VI and VII transition metal carbonyl complexes
    作者:Richard D. Adams、Kellie M. Brosius、O.-Sung Kwon
    DOI:10.1016/s0022-328x(02)01307-4
    日期:2002.6
    thiacrowns by the catalytic ring opening cyclooligomerization of thiirane has been investigated by using some Group VI and Group VII metal carbonyl complexes. The Group VI catalyst precursors were transition metal complexes of the form M(NCCH3)(PR3)x(CO)5−x (x=0, M=Cr, Mo and W; x=1, M=Cr, R=Ph; M=W, R=Ph, or OC6H4–p-Me). For Group VII, the manganese carbonyl cations: [Mn(NCCH3)(L)(CO)4]+, L=CO, PPh3, PMe2Ph
    The synthesis of thiacrowns by the catalytic ring opening cyclooligomerization of thiirane has been investigated by using some Group VI and Group VII metal carbonyl complexes. The Group VI catalyst precursors were transition metal complexes of the form M(NCCH3)(PR3)x(CO)5−x (x=0, M=Cr, Mo and W; x=1, M=Cr, R=Ph; M=W, R=Ph, or OC6H4–p-Me). For Group VII, the manganese carbonyl cations: [Mn(NCCH3)(L)(CO)4]+
  • Studies on Chromium(III) and Vanadium(III) Complexes with Crown Ether and Crown Thioether Coordination – Synthesis, Properties and Structural Systematics
    作者:Charlotte D. Beard、Loretta Carr、Martin F. Davis、John Evans、William Levason、Louise D. Norman、Gillian Reid、Michael Webster
    DOI:10.1002/ejic.200600573
    日期:2006.11
    series of six-coordinate chloro Cr-III and V-III complexes involving crown ether, crown thioether and mixed ether/thioether crowns, [MCl3(crown)] (M = Cr or V, crown = 12-crown-4, 15-crown-5,18-crown-6, [12]aneS(4), [15]aneS(5), [9]aneS(2)O, [15]aneS(2)O(3), [18]aneS(3)O(3)) has been prepared by the reaction of [MCl3(thf)(3)] with rigorously dried crown in anhydrous CH2Cl2. In the presence of small amounts
    一系列涉及冠醚、冠醚和混合醚/醚冠的六配位 Cr-III 和 V-III 配合物,[MCl3(crown)] (M = Cr 或 V,冠 = 12-crown-4, 15 -crown-5,18-crown-6, [12]aneS(4), [15]aneS(5), [9]aneS(2)O, [15]aneS(2)O(3), [18] ]aneS(3)O(3)) 是通过 [MCl3(thf)(3)] 与严格干燥的冠在无 CH2Cl2 中反应制备的。在少量的存在下,获得单物质 [MCl3(H2O)(15-crown-5)] 和 [MCl3( )(18-crown-6)]。产品已通过红外和紫外/可见光谱、微量分析和 [CrCl3( )(18-crown-6)]、[VCl3( )(15-crown-5)] 和 [CrCl3([15] aneS(5))],通过 X 射线晶体学。特别是
  • Crown thioether complexes of trivalent transition metal ions. The crystal structure of [Cr(18S6)Cl3]
    作者:Gregory J. Grant、Karen E. Rogers、William N. Setzer、Donald G. VanDerveer
    DOI:10.1016/0020-1693(95)04462-i
    日期:1995.6
    The structure of the macrocyclic complex, [Cr(18S6)Cl 3 ] (18S6=1,4,7,10,13,16-hexathiacyclooctadecane), has been determined by single-crystal X-ray diffraction, the first Cr(III)-thioether coordination complex to be structurally characterized. An octahedral environment of three sulfur atoms and three chlorine atoms around the Cr(III) center is observed in the complex, and the stereoisomer obtained in
    摘要通过单晶X射线衍射确定了第[Cr(18S6)Cl 3](18S6 = 1,4,7,10,13,16-hexathiacyclooctadecane)的大环配合物的结构,第一个Cr( III)-醚配位化合物要进行结构表征。在该配合物中观察到在Cr(III)中心周围有三个原子和三个原子的八面体环境,在我们的情况下获得的立体异构体是18S6配体中只有三个相邻的原子与CrCl键合的立体异构体。 3部分。这也是18S6配体的这种非典型配位模式的第一个报道结构,该配体通常以六齿形式配位或作为桥连配体配位。描述了一系列其他十一种Cr(III)醚配合物的合成,表征和电子光谱。所有十二种Cr络合物均具有通式CrLCl 3,并且潜在的四齿,五齿和六齿配体均起配位至单个属中心的三齿配体的作用。Cr络合物的电子光谱都很相似,可以很容易地计算出配体场参数。醚起弱电场配体的作用,与用较软的属离
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
hnmr
mass
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)